Effects of Angiotensin II Receptor Blockers on Ventricular Hypertrophy in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
Ye LiuKanako TeramotoVicki K WingThanan SupasiriKanhua YinPublished in: Cardiovascular drugs and therapy (2021)
This meta-analysis showed that ARB treatment is not associated with reduced left ventricular mass nor remarkable LVEF change among patients with hypertrophic cardiomyopathy. Further studies with a larger number of patients will be required to confirm these findings.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- angiotensin ii
- systematic review
- angiotensin converting enzyme
- end stage renal disease
- heart failure
- cardiac resynchronization therapy
- acute myocardial infarction
- ejection fraction
- aortic stenosis
- left atrial
- newly diagnosed
- mitral valve
- chronic kidney disease
- case control
- vascular smooth muscle cells
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- patient reported outcomes
- combination therapy
- atrial fibrillation
- binding protein
- smoking cessation